Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Hub Genes for Early Diagnosis and Predicting Prognosis in Colon Adenocarcinoma. | Biomed Res Int | 2022 | 35774271 | PubTator, text mining | PubMed |
| Glioma Subtypes Based on the Activity Changes of Immunologic and Hallmark Gene Sets in Cancer. | Front Endocrinol (Lausanne) | 2022 | 35774141 | PubTator, text mining | PubMed |
| INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma. | Biosci Rep | 2022 | 35771229 | PubTator, text mining | PubMed |
| BUB1 Is Identified as a Potential Therapeutic Target for Pancreatic Cancer Treatment. | Front Public Health | 2022 | 35769782 | PubTator, text mining | PubMed |
| BubR1 recruitment to the kinetochore via Bub1 enhances spindle assembly checkpoint signaling. | Mol Biol Cell | 2022 | 35767360 | PubTator, text mining | PubMed |
| Expression of HLA and Autoimmune Pathway Genes in Liver Biopsies of Young Subjects With Autoimmune Hepatitis Type 1. | J Pediatr Gastroenterol Nutr | 2022 | 35759748 | PubTator, text mining | PubMed |
| A supervised machine learning approach identifies gene-regulating factor-mediated competing endogenous RNA networks in hormone-dependent cancers. | J Cell Biochem | 2022 | 35757968 | PubTator, text mining | PubMed |
| Immune Cell Networks Uncover Candidate Biomarkers of Melanoma Immunotherapy Response. | J Pers Med | 2022 | 35743743 | PubTator, text mining | PubMed |
| H1299R Variant in Factor V and Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis Protocol. | Genes (Basel) | 2022 | 35741781 | PubTator, text mining | PubMed |
| Prognostic Value of Cancer-Associated Fibroblast-Related Gene Signatures in Hepatocellular Carcinoma. | Front Endocrinol (Lausanne) | 2022 | 35733776 | PubTator, text mining | PubMed |
| Identification of genetic polymorphisms in unexplained recurrent spontaneous abortion based on whole exome sequencing. | Ann Transl Med | 2022 | 35722368 | PubTator, text mining | PubMed |
| Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19. | Front Pharmacol | 2022 | 35721149 | PubTator, text mining | PubMed |
| Identification and Validation of the Diagnostic Characteristic Genes of Ovarian Cancer by Bioinformatics and Machine Learning. | Front Genet | 2022 | 35719392 | PubTator, text mining | PubMed |
| Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomide. | Br J Cancer | 2022 | 35715634 | PubTator, text mining | PubMed |
| KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry. | Medicine (Baltimore) | 2022 | 35713434 | PubTator, text mining | PubMed |
| Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors. | World J Surg Oncol | 2022 | 35710427 | PubTator, text mining | PubMed |
| Identification of hub genes associated with bladder cancer using bioinformatic analyses. | Transl Cancer Res | 2022 | 35706790 | PubTator, text mining | PubMed |
| The Prognostic Signature and Therapeutic Value of Phagocytic Regulatory Factors in Prostate Adenocarcinoma (PRAD). | Front Genet | 2022 | 35706452 | PubTator, text mining | PubMed |
| Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells. | J Clin Invest | 2022 | 35700053 | PubTator, text mining | PubMed |
| Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma. | Nat Commun | 2022 | 35697697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=34